Literature DB >> 12626444

Clearance of virulent but not avirulent Rhodococcus equi from the lungs of adult horses is associated with intracytoplasmic gamma interferon production by CD4+ and CD8+ T lymphocytes.

Stephen A Hines1, Diana M Stone, Melissa T Hines, Debby C Alperin, Donald P Knowles, Linda K Norton, Mary J Hamilton, William C Davis, Travis C McGuire.   

Abstract

Rhodococcus equi is a gram-positive bacterium that infects alveolar macrophages and causes rhodococcal pneumonia in horses and humans. The virulence plasmid of R. equi appears to be required for both pathogenicity in the horse and the induction of protective immunity. An understanding of the mechanisms by which virulent R. equi circumvents protective host responses and by which bacteria are ultimately cleared is important for development of an effective vaccine. Six adult horses were challenged with either virulent R. equi or an avirulent, plasmid-cured derivative. By using a flow cytometric method for intracytoplasmic detection of gamma interferon (IFN-gamma) in equine bronchoalveolar lavage fluid (BALF) cells, clearance of the virulent strain was shown to be associated with increased numbers of pulmonary CD4(+) and CD8(+) T lymphocytes producing IFN-gamma. There was no change in IFN-gamma-positive cells in peripheral blood, suggesting that a type 1 recall response at the site of challenge was protective. The plasmid-cured strain of R. equi was cleared in horses without a significant increase in IFN-gamma-producing T lymphocytes in BALF. In contrast to these data, a previous report in foals suggested an immunomodulating role for R. equi virulence plasmid-encoded products in downregulating IFN-gamma expression by equine CD4(+) T lymphocytes. Intracytoplasmic detection of IFN-gamma provides a method to better determine whether modulation of macrophage-activating cytokines by virulent strains occurs uniquely in neonates and contributes to their susceptibility to rhodococcal pneumonia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12626444      PMCID: PMC150533          DOI: 10.1128/cdli.10.2.208-215.2003

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  43 in total

1.  Intracellular cytokine repertoire in different T cell subsets from patients with sarcoidosis.

Authors:  M Möllers; S P Aries; D Drömann; B Mascher; J Braun; K Dalhoff
Journal:  Thorax       Date:  2001-06       Impact factor: 9.139

2.  Identification of pulmonary T-lymphocyte and serum antibody isotype responses associated with protection against Rhodococcus equi.

Authors:  A Marianela Lopez; Melissa T Hines; Guy H Palmer; Debra C Alperin; Stephen A Hines
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

3.  CD8(+) T cells participate in the memory immune response to Mycobacterium tuberculosis.

Authors:  N V Serbina; J L Flynn
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

4.  Rhodococcus equi: an emerging pathogen.

Authors:  David M Weinstock; Arthur E Brown
Journal:  Clin Infect Dis       Date:  2002-04-25       Impact factor: 9.079

5.  Protective effect of DNA immunization against mycobacterial infection is associated with the early emergence of interferon-gamma (IFN-gamma)-secreting lymphocytes.

Authors:  A T Kamath; N L Groat; A G Bean; W J Britton
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

Review 6.  Cytolytic T cells in the immune response to mycobacterium tuberculosis.

Authors:  S Stenger
Journal:  Scand J Infect Dis       Date:  2001

7.  Long-term persistence and reactivation of T cell memory in the lung of mice infected with respiratory syncytial virus.

Authors:  T Ostler; T Hussell; C D Surh; P Openshaw; S Ehl
Journal:  Eur J Immunol       Date:  2001-09       Impact factor: 5.532

Review 8.  Neonatal and early life vaccinology.

Authors:  C A Siegrist
Journal:  Vaccine       Date:  2001-05-14       Impact factor: 3.641

9.  Interaction of Rhodococcus equi with phagocytic cells from R. equi-exposed and non-exposed foals.

Authors:  S K Hietala; A A Ardans
Journal:  Vet Microbiol       Date:  1987-08       Impact factor: 3.293

10.  Rhodococcus equi foal pneumonia: protective effects of immune plasma in experimentally infected foals.

Authors:  R J Martens; J G Martens; R A Fiske; S K Hietala
Journal:  Equine Vet J       Date:  1989-07       Impact factor: 2.888

View more
  17 in total

1.  Streptolysin-O/antibiotics adjunct therapy modulates site-specific expression of extracellular matrix and inflammatory genes in lungs of Rhodococcus equi infected foals.

Authors:  Volkan Gurel; Kristyn Lambert; Allen E Page; Alan T Loynachan; Katherine Huges; John F Timoney; Michael Fettinger; David W Horohov; John McMichael
Journal:  Vet Res Commun       Date:  2013-03-09       Impact factor: 2.459

2.  Early development of cytotoxic T lymphocytes in neonatal foals following oral inoculation with Rhodococcus equi.

Authors:  Seth P Harris; Melissa T Hines; Robert H Mealey; Debra C Alperin; Stephen A Hines
Journal:  Vet Immunol Immunopathol       Date:  2011-03-21       Impact factor: 2.046

3.  Experimental infection of neonatal foals with Rhodococcus equi triggers adult-like gamma interferon induction.

Authors:  Stephanie Jacks; Steeve Giguère; P Cynda Crawford; William L Castleman
Journal:  Clin Vaccine Immunol       Date:  2007-04-04

4.  Rhodococcus equi-specific cytotoxic T lymphocytes in immune horses and development in asymptomatic foals.

Authors:  Kristin M Patton; Travis C McGuire; Melissa T Hines; Robert H Mealey; Stephen A Hines
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

5.  Interferon-gamma, interleukin-4 and interleukin-10 production by T helper cells reveals intact Th1 and regulatory TR1 cell activation and a delay of the Th2 cell response in equine neonates and foals.

Authors:  Bettina Wagner; Alexandra Burton; Dorothy Ainsworth
Journal:  Vet Res       Date:  2010-04-09       Impact factor: 3.683

6.  Rhodococcus equi secreted antigens are immunogenic and stimulate a type 1 recall response in the lungs of horses immune to R. equi infection.

Authors:  Andrea K Kohler; Diana M Stone; Melissa T Hines; Barbara A Byrne; Debra C Alperin; Linda K Norton; Stephen A Hines
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

7.  Experimental Rhodococcus equi and equine infectious anemia virus DNA vaccination in adult and neonatal horses: effect of IL-12, dose, and route.

Authors:  R H Mealey; D M Stone; M T Hines; D C Alperin; M H Littke; S R Leib; S E Leach; S A Hines
Journal:  Vaccine       Date:  2007-08-15       Impact factor: 3.641

8.  Foal monocyte-derived dendritic cells become activated upon Rhodococcus equi infection.

Authors:  M Julia B F Flaminio; Daryl V Nydam; Hélène Marquis; Mary Beth Matychak; Steeve Giguère
Journal:  Clin Vaccine Immunol       Date:  2008-12-24

9.  Failure of a VapA/CpG oligodeoxynucleotide vaccine to protect foals against experimental Rhocococcus equi pneumonia despite induction of VapA-specific antibody and interferon-γ response.

Authors:  Katharina L Lohmann; A Marianela Lopez; Stephen T Manning; Fernando J Marques; Robert Brownlie; Andrew L Allen; Anna E Sangster; George Mutwiri; Volker Gerdts; Andrew Potter; Hugh G G Townsend
Journal:  Can J Vet Res       Date:  2013-07       Impact factor: 1.310

10.  Vaccination of mice with salmonella expressing VapA: mucosal and systemic Th1 responses provide protection against Rhodococcus equi infection.

Authors:  Aline F Oliveira; Luciana P Ruas; Silvia A Cardoso; Sandro G Soares; Maria-Cristina Roque-Barreira
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.